Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Filbert who wrote (1005)	2/17/2000 5:04:00 PM
From: arnie h	Read Replies (1) \| Respond to of 1386

Filbert: The cost of doing this outside with a CRO is probably about $25-30 million. The kind of CRO who is set up to do this in a number of countries is probably doing work for major companies and getting their timely and full attention would be on ongoing problem. Better we hook up with somebody who has a strong interest in moving things along smartly. Arnie

To: Filbert who wrote (1005)	2/17/2000 5:13:00 PM
From: Gabe Fernandez	Read Replies (1) \| Respond to of 1386

Not familiar with how Phase III studies are arranged but in other studies in Neurotrauma centers a dollar amount is agreed upon and the drug is supplied by the company and the centers conduct the study according to specific guidelines. I do not see any difficulty in the recruiting of centers as long as the drug is safe. The cost has to be negotiated i assume but with the data available from Phase I as reported and what we assume Phase II will show regarding safety and larger dose,i believe that trauma centers would welcome such studies and Pharmos must feel confident that the 7+ million dollars available is sufficient to take this to the next level. Remember if a fast track approval by the FDA is given then the fight is over and the price of the stock should rise dramatically.Possible scenario key events that should alter the price of the stock are 1- Report of Phase II studies. 2- Name of institutions or centers participating in the 3d phase with particular emphasis in Neurotrauma centers in the USA. 3-Press releases due to leaking of information regarding the studies success and finally 4-The block busting announcement that the FDA due to the great results has been forced to grant fast track approval.If any one can send this to Yahoo i will appreciate it . I do not know the mechanics. Finally we should start a PARSIAN club with a projected meeting in 2 years. Tel Aviv or Paris by its name are suggested.gl Hope Tel Aviv wins. Gabe Fernandez. David Israel-Rosen and Ariella and others your input will be appreciated.